๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The Decision to Offer Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

โœ Scribed by Goldman, John M.


Book ID
122907876
Publisher
CIG Media Group, LP.
Year
2006
Tongue
English
Weight
66 KB
Volume
1
Category
Article
ISSN
1931-6925

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Novel tyrosine kinase inhibitor therapy
โœ Elias Jabbour; Jorge Cortes; Hagop Kantarjian; Sergio Giralt; Borje S. Andersson ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 72 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) are increasingly likely to have received a novel tyrosine kinase inhibitor (NTKI) after failing imatinib mesylate. It is unknown whether the use of these NTKI